Company

Cellestia Biotech

Biotechnology Research Basel Basel-town, Ch 8 employees

Employees: 8
Contacts: 3
Emails: 3

www.cellestia.com LinkedIn Crunchbase

Cellestia Biotech Overview

Headquarters: Basel Basel-town, Ch
Website: www.cellestia.com
Industry: Biotechnology Research
Employees: 8
Founded: 2014
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biopharma Oncology Precision Medicine Small Molecules Targeted Therapy Biotech Cancer Therapy Transcription Factors Autoimmune Disorders Inflammatory Disorders

About Cellestia Biotech

Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers. Our clinical stage drug candidate, CB-103, has demonstrated both safety and biological activity in humans. Along with ongoing Phase 2 IITs for multi-drug resistant cancers, CB-103 is also poised to enter a Proof-of-Concept clinical study for graft-versus-host disease (GvHD)

Cellestia Biotech Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Cellestia Biotech Org Chart

Sample employees and titles

Name	Title	Location	Contact
Maria Bobadilla	Chief Development Officer at Cellestia Biotech	Basel, Switzerland	Email
Raj Lehal, Phd	Chief Executive Officer, Cellestia Biotech	Basel, Switzerland	Email
Sebastien Lamy	Research Associate Chez Cellestia Biotech	Lausanne, Vaud, Switzerland	Email
Robert Karsunky	Pharma & Medtech Executive, CFO, Board Member, Investor/advisor		View